Miquel Vila Bover I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR) Instituciones de las que forman parte Jefe de grupo Enfermedades Neurodegenerativas Vall Hebron Institut de Recerca Email Miquel Vila Bover Email Instituciones de las que forman parte Jefe de grupo Enfermedades Neurodegenerativas Vall Hebron Institut de Recerca I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)
I have a degree in Medicine and Surgery from the University of Barcelona (1993) and a PhD in Neuroscience from the University of Paris 6 (1998). My doctoral work carried out in the laboratory of experimental neurology at the Salpetriere Hospital in Paris (1993-98) contributed to establishing the subthalamic nucleus as the main therapeutic target for the surgical treatment of Parkinson's disease with deep brain stimulation. From 1998 to 2005 I worked at the Movement Disorders Unit of Columbia University in New York (USA), initially as a postdoctoral researcher and from 2001 as an Assistant Professor of Neurology, focusing on the study of the mechanisms of neuronal death in Parkinson's disease to identify new therapeutic targets for this currently incurable neurodegenerative disorder. In 2006 I moved to Barcelona as a Professor at ICREA (Catalan Institute of Research and Advanced Studies) to create and lead a new research group in neurodegenerative diseases at the Vall d'Hebron Research Institute (VHIR). Our group is now part of the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) and the Aligning Science Across Parkinson's Collaborative Research Network (ASAP-CRN). I am also an Associate Professor at the Autonomous University of Barcelona, Principal Investigator at CIBERNED, Coordinating Lead PI at ASAP-CRN and member of the Steering Committees of the World Parkinson Coalition and the Basic Science Special Interest Group of the International Parkinson and Movement Disorder Society.
Proyectos Mecanismos y relevancia de la formación de cuerpos de Lewy en la Enfermedad de Parkinson IP: Miquel Vila Bover Colaboradores: Jordi Bove Badell Entidad financiadora: Instituto de Salud Carlos III Financiación: 217679 Referencia: PI071019 Duración: 01/01/2008 - 30/06/2011 Molecular mecanisms of neurodegeneration: targeting programmed cell death as a new therapeutic strategy for Parkinson's disease FP6 Grant No 006505 International Reintegration Grant. MIRG-CT-2004-006505 IP: Miquel Vila Bover Colaboradores: - Entidad financiadora: EUROPEAN COMMISSION Financiación: 80000 Referencia: MIRG-CT-2004-006505 Duración: 13/10/2005 - 13/10/2007 Paper de la disfunció mitocondrial en la mort neuronal de la Malaltia de Parkinson. IP: Miquel Vila Bover Colaboradores: - Entidad financiadora: Fundació Bancària "la Caixa" Financiación: 90000 Referencia: BM06-153-0 Duración: 01/01/2007 - 31/12/2009 Molecular mechanisms of neurodegeneration: targeting programmed cell death as a new therapeutic strategy for Parkinson's disease IP: - Colaboradores: Miquel Vila Bover Entidad financiadora: EUROPEAN COMMISSION Financiación: Referencia: MIRG-CT-2004-006505 Duración: 31/12/2005 - 30/09/2007 Paginación Primera página « Página anterior ‹ … Página 7 Página 8 Página 9 Página actual 10 Página 11 Siguiente página › Última página »
